The Global mRNA Therapeutics Market Size is expected to reach USD 38.15 Billion by 2030, at a CAGR of 2.2% during the forecast period 2022 to 2030. A single protein-coding gene serves as the foundation for protein synthesis in cells and is known as messenger ribonucleic acid (mRNA). The desired immunological characteristics are combined in mRNA vaccines and RNA interference (RNAi) treatments, which are created in labs utilizing mammalian cells.